1804P APEX-01: First-in-human phase I/II study of ARX517 an anti- prostate-specific membrane antigen (PSMA) antibody-drug conjugate (ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Year: 2023
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Institutions: University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, Washington University in St. Louis, Urology Cancer Center and GU Research Network, Indiana University Health, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Winship Cancer Institute, University of California, San Francisco, University of Michigan, University of Washington, Ambrx (United States), NewYork–Presbyterian Hospital, Weill Cornell Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4387810272